Enteropathy Associated T Cell Lymphoma clinical trials

Explore recruiting enteropathy associated t cell lymphoma clinical trials.

Recruiting enteropathy associated t cell lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Enteropathy Associated T Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A safety study of PF-08046045/SGN-35T in adults with advanced cancers

Germany, Spain, Denmark, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Enteropathy Associated T Cell Lymphoma trials by city

Enteropathy Associated T Cell Lymphoma in Toronto Enteropathy Associated T Cell Lymphoma in Vancouver Enteropathy Associated T Cell Lymphoma in Montreal Enteropathy Associated T Cell Lymphoma in Calgary Enteropathy Associated T Cell Lymphoma in Edmonton Enteropathy Associated T Cell Lymphoma in Ottawa Enteropathy Associated T Cell Lymphoma in Winnipeg Enteropathy Associated T Cell Lymphoma in Quebec City Enteropathy Associated T Cell Lymphoma in Hamilton Enteropathy Associated T Cell Lymphoma in Kitchener Enteropathy Associated T Cell Lymphoma in London Enteropathy Associated T Cell Lymphoma in Halifax Enteropathy Associated T Cell Lymphoma in New York Enteropathy Associated T Cell Lymphoma in Los Angeles Enteropathy Associated T Cell Lymphoma in Chicago Enteropathy Associated T Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease